Biological E. Has Received DCGI Approval for Conducting Phase III Comparator Safety & ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'Biological E. has received DCGI approval for conducting Phase III Comparator Safety & Immunogenicity trial in adults after Subject Expert Committee’s review of Phase I and II clinical trials data.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)